You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

circulating tumor DNA (ctDNA) mutation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of Lung Trial in Beijing (Furmonertinib)

Not yet recruiting
  • Adenocarcinoma of Lung
  • Beijing, China
    Peking University People's Hospital
Oct 3, 2021

Circulating Tumor DNA (ctDNA) in Late-stage Breast Cancer

Completed
  • Metastatic Breast Cancer
  • +2 more
  • ctDNA testing
  • (no location specified)
Jun 16, 2022

PDAC - Pancreatic Ductal Adenocarcinoma Trial in Verona (ctDNA analysis)

Recruiting
  • PDAC - Pancreatic Ductal Adenocarcinoma
  • ctDNA analysis
  • Verona, Italy
    AOUI Verona
May 8, 2023

Ovarian Cancer Trial in Roma (Blood samples)

Not yet recruiting
  • Ovarian Cancer
  • Blood samples
  • Roma, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 3, 2023

Circulating Tumor DNA-Guided Late-Line Treatment in Late-Stage

Completed
  • Metastatic Breast Cancer
  • +2 more
  • Control group
  • Case group
  • (no location specified)
Jun 16, 2022

Potential Clinical Utilities of Circulating Tumor DNA in

Not yet recruiting
  • Gastric Cancer
  • Circulating Tumor DNA (ctDNA)
    • (no location specified)
    Aug 21, 2022

    Circulating Tumor DNA Sequencing in Peripheral T-cell Lymphomas

    Not yet recruiting
    • Peripheral T Cell Lymphoma
    • circulating tumoral DNA detection
    • Rouen, France
      Centre Henri Becquerel
    Oct 13, 2023

    Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or

    Recruiting
    • Ovarian Cancer
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Jul 13, 2022

      Detection of Plasma Circulating Tumor DNA in Gastric Cancer

      Recruiting
      • Circulating Tumor DNA (ctDNA)
      • Gastric Cancer
      • plasma circulating tumor DNA
      • Ho Chi Minh City, Vietnam
        University Medical Center Ho Chi Minh City
      Apr 27, 2022

      High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai (ctDNA

      Recruiting
      • High-risk Stage II Colorectal Cancer
      • +2 more
      • ctDNA methylation dynamic monitoring
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Jun 14, 2023

      Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

      Active, not recruiting
      • Melanoma
        • Murray, Utah
        • +1 more
        Feb 17, 2023

        Postoperative Circulating Tumor DNA Monitoring for Colorectal

        Active, not recruiting
        • Colorectal Cancer
        • Serial ctDNA monitoring
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Nov 28, 2023

        NSCLC, Stage III Trial in Indianapolis (Signatera ctDNA test)

        Not yet recruiting
        • NSCLC, Stage III
        • Signatera ctDNA test
        • Indianapolis, Indiana
          Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
        Mar 13, 2023

        Circulating Tumor DNA in Locally Advanced Head and Neck Squamous

        Suspended
        • Head and Neck Neoplasm
        • Carcinoma, Squamous Cell
        • Blood and tumor samples
        • Chapel Hill, North Carolina
          University of North Carolina at Chapel Hill
        Feb 24, 2022

        Locally Advanced Rectal Carcinoma, Circulating Tumor DNA Trial in Beijing (circulating tumor DNA)

        Recruiting
        • Locally Advanced Rectal Carcinoma
        • Circulating Tumor DNA
        • circulating tumor DNA
        • Beijing, Beijing, China
          Department of General Surgery, Peking Union Medical College Hosp
        Oct 27, 2022

        Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

        Not yet recruiting
        • Uveal Melanoma
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Oct 5, 2023

        Pancreatic Cancer Trial in Seoul (cell free DNA in blood, genetic mutation in tissue)

        Recruiting
        • Pancreatic Cancer
        • cell free DNA in blood, genetic mutation in tissue
        • Seoul, Korea, Republic of
          Seoul National University Hospital
        Nov 2, 2022

        ctDNA in Muscle-invasive Bladder Cancer Treated With Trimodality

        Recruiting
        • Bladder Cancer
        • Muscle-Invasive Bladder Carcinoma
          • Chapel Hill, North Carolina
            North Carolina Cancer Hospital (UNC)
          Jan 11, 2023

          Adenocarcinoma Esophagus Trial in Milwaukee (Circulating tumor DNA(ctDNA) level measurement)

          Recruiting
          • Adenocarcinoma Esophagus
          • Circulating tumor DNA(ctDNA) level measurement
          • Milwaukee, Wisconsin
            Froedtert Hospital and the Medical College of Wisconsin
          May 23, 2022

          Diffuse Large B Cell Lymphoma Trial in Rouen (Measure of the circulating tumor DNA)

          Not yet recruiting
          • Diffuse Large B Cell Lymphoma
          • Measure of the circulating tumor DNA
          • Rouen, France
            Centre Henri Becquerel
          Nov 17, 2023

          Appendiceal Adenocarcinoma, Colorectal Trial in Houston (Circulating tumoral DNA directed neoadjuvant therapy arm)

          Not yet recruiting
          • Appendiceal Adenocarcinoma
          • Colorectal
          • Circulating tumoral DNA directed neoadjuvant therapy arm
          • Houston, Texas
            M D Anderson Cancer Center
          Jul 7, 2023

          NSCLC Trial (Furmonertinib, Furmonertinib/Pemetrexed/Carboplatin, Furmonertinib/Pemetrexed/Carboplatin/Bevacizumab)

          Recruiting
          • Non-small Cell Lung Cancer
          • Changchun, China
          • +25 more
          Aug 26, 2022

          Colorectal Cancer Trial in Guangzhou (Detection of ctDNA methylation)

          Recruiting
          • Colorectal Cancer
          • Detection of ctDNA methylation
          • Guangzhou, Guangdong, China
            Nanfang Hospital, Southern Medical University
          Sep 25, 2022

          OPTImal PALliative Anti-epidermal Growth Factor Receptor

          Active, not recruiting
          • Colorectal Cancer Metastatic
          • +5 more
          • Plasma circulating DNA analysis
          • Aarhus, Denmark
            Aarhus University Hospital
          Feb 24, 2022

          ctDNA Methylation for Epithelial Ovarian Cancer

          Recruiting
          • Epithelial Ovarian Cancer
          • +7 more
          • CDO1 and HOXA9 methylation assay
          • Beijing, Beijing, China
            Lei Li
          Mar 24, 2023